Ngā hua rapu - Ouppatham Supasyndh
- E whakaatu ana i te 1 - 8 hua o te 8
-
1
-
2
-
3
-
4
-
5
Efficacy and Safety of Sacubitril/Valsartan (LCZ696) Compared With Olmesartan in Elderly Asian Patients (≥65 Years) With Systolic Hypertension mā Ouppatham Supasyndh, Jianan Wang, Kudsia Hafeez, Ying Zhang, Jack Zhang, Hiromi Rakugi
I whakaputaina 2017Artigo -
6
-
7
Effect of Oral Anabolic Steroid on Muscle Strength and Muscle Growth in Hemodialysis Patients mā Ouppatham Supasyndh, Bancha Satirapoj, Pornanong Aramwit, Duangkamol Viroonudomphol, Amnart Chaiprasert, Vipa Thanachatwej, Supat Vanichakarn, Joel D. Kopple
I whakaputaina 2012Artigo -
8
Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension mā Kazuomi Kario, Ningling Sun, Fu‐Tien Chiang, Ouppatham Supasyndh, Sang Hong Baek, Akiko Inubushi-Molessa, Ying Zhang, Hiromi Gotou, Martin Lefkowitz, Jack Zhang
I whakaputaina 2014Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Endocrinology
Gastroenterology
Pathology
Alternative medicine
Cardiology
Dialysis
Hemodialysis
Nephrology
Placebo
Angiotensin II
Biology
Blood pressure
Environmental health
Kidney disease
Population
Surgery
Valsartan
Acute kidney injury
Albuminuria
Ambulatory blood pressure
Anabolism
Biochemistry
Body weight
Cell biology
Dermatology
Diabetes mellitus
Diabetic nephropathy
Diastole